AUDIENCE: Patient,
Consumer, Health Professional, Risk Manager, Veterinary Medicine
ISSUE: FDA is
alerting patients and health care professionals not to use certain
compounded products produced and distributed by Drug Depot, LLC, doing
business as APS Pharmacy intended to be sterile, due to lack of
sterility assurance. Administration of non-sterile products intended to
be sterile may result in serious and potentially life-threatening
infections or death.
The
recalled drugs include “gonadorelin acetate,” “testosterone cypionate
in grapeseed oil,” “testosterone cypionate/anastrozole in grapeseed
oil,” “testosterone cypionate/DHEA in grapeseed oil,” and “testosterone
cypionate/propionate in sesame seed oil” for human use, and
“cyclosporin” and “tacrolimus” for animal ophthalmic use. These
products were compounded between December 21, 2021, and March 7, 2022.
The recalled drugs, lot numbers, and do-not-use beyond date - the date
when the compounded drug should no longer be used - are listed here.
Since the
company initiated the recall and began contacting patients using the
recalled drugs, FDA has received adverse event reports from APS
Pharmacy regarding injection site reactions, such as pain, redness,
swelling and abscesses requiring medical treatment; and systemic
reactions, which include fever, chills, and rash. To date, FDA has
received two reports of adverse events occurring in animals following
use of the recalled animal ophthalmic products.
For more
information about this alert, click on the red button "Read Alert" below.
BACKGROUND: APS
Pharmacy initiated the nationwide recall via a recall letter dated
March 15, 2022. The company has sent recall letters to patients and
animal owners who received the recalled drugs, and they are contacting
customers via telephone calls and emails as part of their recall
strategy.
RECOMMENDATIONS:
- Health
care professionals and veterinarians should immediately check
their medical supplies, quarantine any recalled drugs from APS
Pharmacy, and not administer or provide them to patients or
animals.
- Patients
should not use, and animal owners/caretakers should not administer,
the recalled drugs from APS Pharmacy. If they are not sure if they
have a recalled drug, they should contact APS pharmacy to confirm.
- Patients
and animal owners/caretakers who have received these recalled
drugs from APS Pharmacy should contact their health care
professional/veterinarian as appropriate.
- FDA
urges health care professionals and consumers who obtained
recalled drugs to make alternative arrangements to obtain
medications from sources that meet applicable quality standards.
|